We're counting down the days until we see our customers, partners, and the #digitalpathology community in London at #DigiPathGE. Visit exhibit 41 to see why 14 of the top 20 pharma companies and major diagnostic laboratories rely on Concentriq. 📅 Book a meeting here: bit.ly/3CIxjUd
Proscia
Software Development
Philadelphia, Pennsylvania 15,278 followers
Proscia is fighting cancer by changing the way the world practices pathology. Join us.
About us
Proscia is fighting cancer with intelligent software that changes the way the world practices pathology. Join us.
- Website
-
http://www.proscia.com
External link for Proscia
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- Philadelphia, Pennsylvania
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Computer Software, Cancer, and Cloud Computing
Locations
-
Primary
Get directions
1700 Market St
23rd Floor
Philadelphia, Pennsylvania 19103, US
Employees at Proscia
Updates
-
A big thank you to Dennis Strenk for another great episode!
Pathologists’ Assistant at Wisconsin Diagnostic Laboratories, Host of People of Pathology Podcast #PathAShadow
In this new episode Julianna Ianni and I dive into the fascinating world of Foundation Models and their potential impact on #pathology. And we discuss Proscia's Concentriq Embeddings. Listen now: Apple: https://lnkd.in/gZq5uut Spotify: https://lnkd.in/gHqNMcb YouTube: https://lnkd.in/gTpuQhF6 Doc Social: https://lnkd.in/gSJdfJhP
-
What does 2025 have in store? 🔮 Check out the predictions from these industry experts, including our very own Nathan Buchbinder, on the leading clinical laboratory trends for 2025. Read the whole article from Clinical Lab Products’ Chris Wolski: https://lnkd.in/gby5FDMU
-
If you missed our partner Agilent Dako Pathology Solutions’ symposium at #ECP2024, there's still a chance for you to catch it. You can access their on-demand symposium featuring key opinion leaders, including Dr. Tolonen from our customer Fimlab. He shares valuable insights into his organization’s #digitalpathology journey and next steps with AI.
🔬 Digital Pathology On-Demand Symposium 🔬 Discover how Digital Pathology is transforming laboratory processes, enhancing clinical utility, and setting new standards in improving patient outcomes across the board. Join us for this insightful seminar with four key opinion leaders, featuring real-world examples of agnostic, end-to-end solutions that are driving impactful results in pathology labs worldwide. https://lnkd.in/efX295ty 👉 Ready to learn how digital pathology can elevate your lab? Don’t miss this opportunity! #DigitalPathology #LaboratoryEfficiency #PathologySolutions #PatientOutcomes D0122465_1.00
-
-
We were named to Fast Company's Next Big Things in Tech! 🏆 This list recognizes breakthrough technologies that have a profound impact on the industries they serve. Our Concentriq was named to the Health category for rewiring cancer research and diagnosis. Thank you to our customers, partners, team, and the #digitalpathology community for joining us on our mission. And a big congratulations to our fellow winners. https://bit.ly/490hm87
-
-
We've partnered with Owkin to streamline MSI testing for patients with colorectal cancer (CRC), the second most deadly cancer worldwide. As a first step, we'll integrate MSIntuit CRC v2 with Concentriq for studying its impact and make it available as part of our precision medicine AI portfolio. The MSI biomarker plays an important role in managing CRC. Together with Owkin, we look forward to helping laboratories meet guidelines for universal screening by expanding access to the AI solution. Owkin has also joined the Proscia Ready partner alliance. “We are thrilled to partner with Proscia and execute on our shared vision of harnessing the power of AI to transform medical research and diagnosis. Together, we will expand access to our digital diagnostics for patients globally.” - Dr. Thomas Clozel, CEO of Owkin Read the full release here: https://bit.ly/3CzyeXb #digitalpathology
-
For Concentriq users eager to start developing with Concentriq Embeddings, the Proscia AI Toolkit offers a suite of open-source resources designed to make the development process effortless. The toolkit features: 🔧A Python client for seamless API integration with Concentriq Embeddings. 🔧Comprehensive tutorials paired with Python code in Jupyter Notebooks, enabling users to learn and implement AI quickly. 🔧A growing library of helper functions for tasks like image tiling and organizing API outputs, reducing the complexity of common processes. Start building today: https://lnkd.in/egJfFuDg
-
-
With increasing R&D investment, CROs are adopting #digitalpathology platforms to meet demands for faster, high-quality results. We’d love to hear from you on how these solutions are transforming the industry. Let us know what you think below.
This content isn’t available here
Access this content and more in the LinkedIn app
-
Did you know? Our Concentriq enterprise pathology platform offers a precision medicine AI portfolio of over 150 research and diagnostic applications. Check it out here: bit.ly/3Y6i0Nx Ibex Medical Analytics, Visiopharm, DoMore Diagnostics, Stratipath, Mindpeak GmbH, Nucleai